NCT00529945

PFx Closure System in Subjects With Cryptogenic Stroke, TIA, Migraine or Decompression Illness

The Paradigm IV Trial - PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Cierra · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The primary object of this study is to demonstrate the continued safety and performance of the PFx Closure System when utilized for patients with PFOs suffering from cryptogenic stroke, transient ischemic attack, migraine or decompression illness.

Conditions

• PFO
• Stroke
• Transient Ischemic Attack
• Migraine
• Decompression Illness

Interventions

Type	Name	Description
DEVICE	PFx Closure System

Timeline

• Start date: 2007-08-01
• Completion: 2007-12-01
• First posted: 2007-09-14
• Last updated: 2007-12-21

Locations

1 site across 1 country: Germany